[ET Net News Agency, 15 April 2024] LEPU BIO-B (02157) rose 11% to HK$4.25.
It hits an intra-day high of HK$4.28, hitting an 1-month high, and an intra-day low of
HK$3.83. The total shares traded was 980,000, with a value of HK$3.94m. The active
buy/sell ratio is 79:21, with net buying turnover of HK$2.21m. WINBULL SEC INT'L accounts
for greatest net responsive buying turnover of HK$7,660, with volume weighted average
price of HK$3.83. CHINA INNOVATION MARKET SER accounts for greatest net responsive selling
turnover of HK$605,373, with volume weighted average price of HK$4.049. The stock has
risen a combined 28% over the past 6 consecutive trading days.
Basic Information
=================
-----------------------------------
Nominal 4.250 % Chg +10.97%
High 4.280 Low 3.830
Shares Tr 980,000 Turnover 3.94m
10-D SMA 3.591 %H.V 53.545
20-D SMA 3.411 VWAP 4.020
50-D SMA 3.448 RSI14 75.476
-----------------------------------
Status: Hitting an 1-month high, active buy/sell ratio is 79:21, with net buying turnover
of HK$2.21m, rising a combined 28% over the past 6 consecutive trading days
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
-----------------------------------------------
LEPU BIO-B (02157) 4.25 +10.97
GENSCRIPT BIO (01548) 12.24 -4.08
INNOVENT BIO (01801) 35.85 -4.02
EVEREST MED-B (01952) 24.75 -5.35
WUXI BIO (02269) 13.68 -1.58
TIGERMED (03347) 33.30 +3.26
BEIGENE (06160) 83.35 -2.74
SCICLONE PHARMA (06600) 18.08 +0.67
AKESO (09926) 48.40 -2.22
REMEGEN (09995) 29.50 -8.53
-----------------------------------------------
(ed)